OKYO Pharma Ltd. (OKYO)
1.40
-0.07
(-4.76%)
USD |
NASDAQ |
Oct 23, 16:00
1.44
+0.04
(+2.86%)
After-Hours: 20:00
OKYO Pharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Silence Therapeutics Plc | 0.0029 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 0.0332 |
| Mereo BioPharma Group Plc | 0.0359 |
| Compass Pathways Plc | 0.6462 |